Skip to main content
. 2026 Aug 6;18(8):965. doi: 10.3390/pharmaceutics18080965
2-NBDG 2-(N-(7-Nitrobenz-2-oxa-1,3-diazol-4-yl)amino)-2-deoxyglucose
BBD Box–Behnken Design
DCFH-DA 2′,7′-Dichlorodihydrofluorescein diacetate
DOTAP 1,2-Dioleoyloxy-3-trimethylammonium propane chloride
DPPH 2,2-Diphenyl-1-picrylhydrazyl
FRAP Ferric Reducing Antioxidant Power
MD Mean Diameter
mg GAE/g milligrams of Gallic Acid Equivalents per gram of dry extract
mg TE/g milligrams of Trolox Equivalents per gram of dry extract
MTT 3-[4,5-dimethylthiazol-2-yl]-2,5 diphenyl tetrazolium bromide
NAC N-acetyl-L-cysteine
OE Optimized olive leaf extract
OE Eu-LIP Optimized olive leaf extract in Eu-liposomes
OE sol Optimized olive leaf extract in solution
P90G Phospholipon® 90G
PBS Phosphate Buffered Saline
PI Polydispersity Index
RSM Response Surface Methodology
SGF Simulated Gastric Fluid
SIF Simulated Intestinal Fluid
T2DM Type 2 diabetes mellitus
TPC Total Phenolic Content
TPTZ 2,4,6-Tripyridyl-s-triazina
Trolox 6-Hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid
USP United States Pharmacopoeia
ZP Zeta Potential